UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

2019-04-18 12:14:31 | BioPortfolio

Published on BioPortfolio: 2019-04-18T12:14:31-0400

Clinical Trials [5019 Associated Clinical Trials listed on BioPortfolio]

Randomized Double Cord Blood Transplant Study

Primary objective: In a prospective, phase II randomized study, to evaluate the transplantation of two unmanipulated cord blood units ("double cord blood" transplant) versus one unmanipul...

P3 Study of Umbilical Cord Blood Cells Expanded With MPCs for Transplantation in Patients With Hematologic Malignancies

The study investigates the time to engraftment of a mesenchymal expanded cord blood unit in patients with hematologic malignancies undergoing transplantation with myeloablative conditionin...

Infusion of Myeloid Progenitors to Speed Neutrophil Recovery After Umbilical Cord Blood Transplant in Patients With Hematologic Malignancy

RATIONALE: Donor bone marrow cells that have been treated in the laboratory may help patients with high-risk hematologic cancer recover from donor umbilical cord blood transplant. P...

Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

Allogeneic hematopoietic stem cell transplantation is a life-saving procedure in patients with blood cancers, but only 25% of transplant candidates have a sibling donor. A matched unrelate...

Cord Blood (CB) Ex-vivo Mesenchymal Stem Cell (MSC) Expansion + Fucosylation

The goal of this clinical research study is to learn if giving 1 unit of expanded cord blood combined with 1 unit of non-expanded cord blood to a patient with leukemia or lymphoma can help...

PubMed Articles [32468 Associated PubMed Articles listed on BioPortfolio]

Fluoroquinolone prophylaxis is highly effective for the prevention of central line-associated bloodstream infections in autologous stem cell transplant patients.

Patients undergoing stem cell transplant (SCT) for the treatment of hematologic malignancy are at increased risk for central line-associated bloodstream infections (CLABSIs). The use of prophylactic a...

Reducing ethnic disparity in access to high-quality HLA-matched cord blood units for transplantation: analysis of the Canadian Blood Services' Cord Blood Bank inventory.

Launched in 2013, Canadian Blood Services' Cord Blood Bank (CBS' CBB) has built a high-quality, ethnically diverse cord blood repository that aims to reduce ethnic disparity in accessing suitable unit...

Nucleated red blood cells as a novel indicator of CD34 cell content in umbilical cord blood.

Umbilical cord blood (UCB) has become an important source of transplantable CD34 hematopoietic progenitor cells. Cord blood banks (CBBs) can increase their efficiency by minimizing the processing of U...

Risk factors and predictive scoring system for post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation.

We analyzed data of 64,539 consecutive patients in the national Japanese transplant registry, including 40,195 after allogeneic stem cell transplantation, 24,215 after autologous stem cell transplanta...

Killer-cell immunoglobulin-like receptor ligand mismatch cord blood transplantation in high-risk neuroblastoma.

The prognosis of high-risk neuroblastoma-stage 4 with bone marrow metastasis, MYCN amplified, or refractory neuroblastoma is poor. To date, no standard treatment has been established. In an attempt to...

Medical and Biotech [MESH] Definitions

The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.

Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery.

Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.

Disorders of the blood and blood forming tissues.

Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.

More From BioPortfolio on "UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia"

Quick Search


Searches Linking to this Trial